D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 51 Citations 12,202 120 World Ranking 3182 National Ranking 278

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Bacteria
  • Antibiotics

His primary scientific interests are in Microbiology, Burkholderia cepacia complex, Burkholderia, Cystic fibrosis and Pseudomonas aeruginosa. John R. W. Govan is studying Antibiotic resistance, which is a component of Microbiology. His Burkholderia cepacia complex research focuses on Burkholderia cenocepacia and how it relates to Pathogen.

His studies in Burkholderia integrate themes in fields like Genome and Microbial ecology. His Cystic fibrosis research is multidisciplinary, incorporating perspectives in Surgery and Immunology. The Immunology study combines topics in areas such as Gastroenterology and Internal medicine, Lung.

His most cited work include:

  • Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. (1505 citations)
  • Taxonomy and Identification of the Burkholderia cepacia Complex (382 citations)
  • Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic (340 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Microbiology, Cystic fibrosis, Pseudomonas aeruginosa, Immunology and Burkholderia cepacia complex. His studies in Microbiology integrate themes in fields like Genomovar, Virulence and Burkholderia, Bacteria. John R. W. Govan has researched Cystic fibrosis in several fields, including Antibiotics, Infection control and Pseudomonas.

As a part of the same scientific study, he usually deals with the Pseudomonas aeruginosa, concentrating on Antibiotic resistance and frequently concerns with Tobramycin. The various areas that John R. W. Govan examines in his Immunology study include Respiratory disease, Internal medicine, Lung, Bronchiectasis and Gastroenterology. His Burkholderia cepacia complex study combines topics in areas such as Bacteriophage and Burkholderia cenocepacia.

He most often published in these fields:

  • Microbiology (64.75%)
  • Cystic fibrosis (43.44%)
  • Pseudomonas aeruginosa (43.44%)

What were the highlights of his more recent work (between 2010-2018)?

  • Cystic fibrosis (43.44%)
  • Immunology (25.41%)
  • Microbiology (64.75%)

In recent papers he was focusing on the following fields of study:

John R. W. Govan mainly focuses on Cystic fibrosis, Immunology, Microbiology, Pseudomonas aeruginosa and Bronchiectasis. His work deals with themes such as Antibiotics, Mannan-binding lectin, MBL deficiency and Negative regulator, which intersect with Cystic fibrosis. His Immunology study incorporates themes from Fibrosis, Pathology and Lung.

His research integrates issues of Acute appendicitis, Molecular typing and Pseudomonas in his study of Microbiology. His Pseudomonas aeruginosa research includes themes of Gene, Whole genome sequencing, Mutation and Virology. His Bronchiectasis study integrates concerns from other disciplines, such as Gastroenterology, Exacerbation, Haemophilus influenzae and Neutrophil elastase.

Between 2010 and 2018, his most popular works were:

  • Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis (240 citations)
  • A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis (213 citations)
  • Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection (148 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Gene
  • Antibiotics

The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Bronchiectasis, Immunology and Cystic fibrosis. His work on Severity of illness, Vitamin, Case-control study and Incidence as part of general Internal medicine research is frequently linked to vitamin D deficiency, thereby connecting diverse disciplines of science. His Bronchiectasis study deals with Exacerbation intersecting with Intensive care, Randomized controlled trial, Antibacterial agent, Anesthesia and Lung.

His Cystic fibrosis study typically links adjacent topics like Surgery. His study looks at the intersection of Surgery and topics like Respiratory infection with Pseudomonas aeruginosa. John R. W. Govan usually deals with Pseudomonas aeruginosa and limits it to topics linked to In vivo and Microbiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

J. R.W. Govan;V. Deretic.
Microbiological Research (1996)

2391 Citations

Taxonomy and Identification of the Burkholderia cepacia Complex

Tom Coenye;Peter Vandamme;John R. W. Govan;John J. LiPuma.
Journal of Clinical Microbiology (2001)

601 Citations

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

K. Cheng;R. L. Smyth;J. R. W. Govan;C. Doherty.
The Lancet (1996)

483 Citations

Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis

James D. Chalmers;Maeve P. Smith;Brian J. McHugh;Cathy Doherty.
American Journal of Respiratory and Critical Care Medicine (2012)

389 Citations

Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex

Eshwar Mahenthiralingam;Tom Coenye;Jacqueline W. Chung;David P. Speert.
Journal of Clinical Microbiology (2000)

387 Citations

The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients

Matthew T. G. Holden;Helena M. B. Seth-Smith;Lisa C. Crossman;Mohammed Sebaihia.
Journal of Bacteriology (2009)

371 Citations

Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov.

Tom Coenye;Enevold Falsen;Marc Vancanneyt;Bart Hoste.
International Journal of Systematic and Evolutionary Microbiology (1999)

360 Citations

A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis

Maeve P. Murray;John R. W. Govan;Catherine J. Doherty;A. John Simpson.
American Journal of Respiratory and Critical Care Medicine (2011)

333 Citations

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic

Andrew M. Jones;John R W Govan;Catherine J. Doherty;Mary E. Dodd.
The Lancet (2001)

323 Citations

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis

A M Jones;M E Dodd;J R W Govan;V Barcus.
Thorax (2004)

299 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John R. W. Govan

Peter Vandamme

Peter Vandamme

Ghent University

Publications: 132

Miguel A. Valvano

Miguel A. Valvano

Queen's University Belfast

Publications: 104

John J. LiPuma

John J. LiPuma

University of Michigan–Ann Arbor

Publications: 90

Tom Coenye

Tom Coenye

Ghent University

Publications: 79

Eshwar Mahenthiralingam

Eshwar Mahenthiralingam

Cardiff University

Publications: 73

Leo Eberl

Leo Eberl

University of Zurich

Publications: 58

Craig Winstanley

Craig Winstanley

University of Liverpool

Publications: 55

Scott C. Bell

Scott C. Bell

University of Queensland

Publications: 53

Niels Høiby

Niels Høiby

University of Copenhagen

Publications: 53

David P. Speert

David P. Speert

University of British Columbia

Publications: 48

Jean Swings

Jean Swings

Federal University of Rio de Janeiro

Publications: 48

Daniel J. Wozniak

Daniel J. Wozniak

The Ohio State University

Publications: 47

Robert E. W. Hancock

Robert E. W. Hancock

University of British Columbia

Publications: 44

Vojo Deretic

Vojo Deretic

University of New Mexico

Publications: 41

Pamela A. Sokol

Pamela A. Sokol

University of Calgary

Publications: 41

Keith Grimwood

Keith Grimwood

Griffith University

Publications: 37

Trending Scientists

Richard D. Gitlin

Richard D. Gitlin

University of South Florida

Mark J. Stevens

Mark J. Stevens

Sandia National Laboratories

Kristof Van Hecke

Kristof Van Hecke

KU Leuven

Helena E. Richardson

Helena E. Richardson

La Trobe University

Christer Erséus

Christer Erséus

University of Gothenburg

Yiping Tong

Yiping Tong

Chinese Academy of Sciences

Edouard M. Bevers

Edouard M. Bevers

Maastricht University

Cecilia B. Moens

Cecilia B. Moens

Fred Hutchinson Cancer Research Center

Markus Moser

Markus Moser

Technical University of Munich

Gregory E. Glass

Gregory E. Glass

University of Florida

Edward J. Brook

Edward J. Brook

Oregon State University

Spencer G. Lucas

Spencer G. Lucas

American Museum of Natural History

Nadine Salzmann

Nadine Salzmann

University of Fribourg

Simone Orlandini

Simone Orlandini

University of Florence

Margot J. Taylor

Margot J. Taylor

University of Toronto

Christopher L. Wolfgang

Christopher L. Wolfgang

New York University

Something went wrong. Please try again later.